- call +1-201-465-4211
- email sales@mrinsights.biz
Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.
Scope of the Report:
This report studies the Next Generation Diabetes Therapy and Drug Delivery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Next Generation Diabetes Therapy and Drug Delivery market by product type and applications/end industries.
The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.
Asia-Pacific possesses high market potential for the growth of next generation diabetes therapy and drug delivery market, owing to increase in demand for advanced diabetic products, high incidence of diabetes, and rise in healthcare expenditure. It has experienced fast-paced growth, in terms of production and development of advanced diabetic products.
The global Next Generation Diabetes Therapy and Drug Delivery market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Next Generation Diabetes Therapy and Drug Delivery.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Johnson & Johnson
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Market Segment by Applications, can be divided into
Diagnostic/Clinics
ICUs
Home Healthcare
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Next Generation Diabetes Therapy and Drug Delivery Market Overview
1.1 Product Overview and Scope of Next Generation Diabetes Therapy and Drug Delivery
1.2 Classification of Next Generation Diabetes Therapy and Drug Delivery by Types
1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Comparison by Types (2017-2023)
1.2.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Types in 2017
1.2.3 Inhalable Insulin
1.2.4 Oral Insulin
1.2.5 Insulin Patches
1.2.6 CGM Systems
1.2.7 Artificial Pancreas
1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market by Application
1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Global Next Generation Diabetes Therapy and Drug Delivery Market by Regions
1.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next Generation Diabetes Therapy and Drug Delivery Status and Prospect (2013-2023)
1.5 Global Market Size of Next Generation Diabetes Therapy and Drug Delivery (2013-2023)
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott Laboratories
2.2.1 Business Overview
2.2.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.3 Medtronic
2.3.1 Business Overview
2.3.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novo Nordisk
2.5.1 Business Overview
2.5.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.6 MannKind Corporation
2.6.1 Business Overview
2.6.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.7 Enteris BioPharma
2.7.1 Business Overview
2.7.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.8 Dexcom
2.8.1 Business Overview
2.8.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.9 Senseonics
2.9.1 Business Overview
2.9.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.10 Medtech
2.10.1 Business Overview
2.10.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.11 Synertech
2.11.1 Business Overview
2.11.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.12 Zosano Pharma
2.12.1 Business Overview
2.12.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.13 Relmada Therapeutics
2.13.1 Business Overview
2.13.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.14 Eli Lilly and Company
2.14.1 Business Overview
2.14.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
2.15 Transdermal Specialties
2.15.1 Business Overview
2.15.2 Next Generation Diabetes Therapy and Drug Delivery Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2016-2017)
3 Global Next Generation Diabetes Therapy and Drug Delivery Market Competition, by Players
3.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Next Generation Diabetes Therapy and Drug Delivery Players Market Share
3.2.2 Top 10 Next Generation Diabetes Therapy and Drug Delivery Players Market Share
3.3 Market Competition Trend
4 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Market Share by Regions
4.2 North America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
4.3 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
4.5 South America Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
5 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries
5.1 North America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)
5.2 USA Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
5.3 Canada Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
5.4 Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
6 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries
6.1 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)
6.2 Germany Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
6.3 UK Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
6.4 France Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
6.5 Russia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
6.6 Italy Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries
7.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)
7.2 China Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
7.3 Japan Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
7.4 Korea Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
7.5 India Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
8 South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries
8.1 South America Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)
8.2 Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
8.3 Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
8.4 Colombia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Next Generation Diabetes Therapy and Drug Delivery by Countries
9.1 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue by Countries (2013-2018)
9.2 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
9.3 UAE Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
9.4 Egypt Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
9.5 Nigeria Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
9.6 South Africa Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2013-2018)
10 Global Next Generation Diabetes Therapy and Drug Delivery Market Segment by Type
10.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue and Market Share by Type (2013-2018)
10.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Type (2018-2023)
10.3 Inhalable Insulin Revenue Growth Rate (2013-2023)
10.4 Oral Insulin Revenue Growth Rate (2013-2023)
10.5 Insulin Patches Revenue Growth Rate (2013-2023)
10.6 CGM Systems Revenue Growth Rate (2013-2023)
10.7 Artificial Pancreas Revenue Growth Rate (2013-2023)
11 Global Next Generation Diabetes Therapy and Drug Delivery Market Segment by Application
11.1 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2013-2018)
11.2 Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Application (2018-2023)
11.3 Diagnostic/Clinics Revenue Growth (2013-2018)
11.4 ICUs Revenue Growth (2013-2018)
11.5 Home Healthcare Revenue Growth (2013-2018)
12 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2018-2023)
12.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast (2018-2023)
12.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Forecast by Regions (2018-2023)
12.3 North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)
12.4 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)
12.6 South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Next Generation Diabetes Therapy and Drug Delivery Picture
Table Product Specifications of Next Generation Diabetes Therapy and Drug Delivery
Table Global Next Gener
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
